Polycyclo Ring System Patents (Class 568/732)
  • Patent number: 4642373
    Abstract: 1,2,3,4,4a,4b,5,6,7,8,8a,12b-Dodecahydro-7-(oxo, hydroxy or amino)-9-hydroxy-11-(alkyl, alkoxy or alkoxyalkyl)triphenylenes, 2,3,3a,3b,4,5,6,7,7a,11b-decahydro-6-(oxo, hydroxy or amino)-8-hydroxy-10-(alkyl, alkoxy or alkoxyalkyl)-1H-cyclopenta[1]-phenanthrenes, 2,3,4,4a,4b,5,6,7,8,8a-decahydro-7-(oxo, hydroxy or amino)-9-hydroxy-11-(alkyl, alkoxy, alkoxyalkyl, aralkyl, aralkoxy, aryloxyalkyl or aralkoxyalkyl)-1H-pyrido[1,2-f]phenanthridines, and 1,2,3,3a,3b,4,5,6,7,7a-decahydro-6-(oxo, hydroxy or amino)-8-hydroxy-10-(alkyl, alkoxy or alkoxyalkyl)pyrrolo[1,2-f]phenanthridines and derivatives are valuable as central nervous system active agents or as intermediates to compounds having such activity.
    Type: Grant
    Filed: July 6, 1984
    Date of Patent: February 10, 1987
    Assignee: Pfizer Inc.
    Inventors: James F. Eggler, Michael R. Johnson, Lawrence S. Melvin, Jr.
  • Patent number: 4590301
    Abstract: Compounds of the general formula ##STR1## wherein n, R.sub.1, R.sub.2 and X are defined herein, are effective inhibitors of polymerization of vinylic monomers, particularly acrylic monomers. The inhibitors are easily, efficiently, and thoroughly removed from solution with the monomer by contact with charcoal.
    Type: Grant
    Filed: October 24, 1984
    Date of Patent: May 20, 1986
    Assignee: Barnes-Hind, Inc.
    Inventors: Drahoslav Lim, Peter C. Morris
  • Patent number: 4484010
    Abstract: Hindered hydroxybenzylcyclopentadienes and derivatives thereof, useful as antioxidants, are prepared by reacting cyclopentadiene, an alkali metal, and a hindered p-methylphenol having a displaceable group attached to the methyl group in the presence of a non-protic solvent; or in one step, by reacting cyclopentadiene, hindered phenol that is devoid of a group in the para position, formaldehyde, an amine, water, and an alkali metal hydroxide in the presence of a phase transfer catalyst; or in one step, by reacting cyclopentadiene and a hindered substituted p-methyl-phenol containing a displaceable group, in the presence of a non-protic solvent, water, an alkali metal hydroxide and a phase transfer catalyst. These compounds readily dimerize whereas the bis compounds are prepared in presence of an excess amount of the substituted p-methylphenol.
    Type: Grant
    Filed: January 10, 1983
    Date of Patent: November 20, 1984
    Assignee: The B. F. Goodrich Company
    Inventor: Robert W. Layer
  • Patent number: 4473704
    Abstract: 1,2,3,4,4a,4b,5,6,7,8,8a,12b-Dodecahydro-7-(oxo, hydroxy or amino)-9-hydroxy-11-(alkyl, alkoxy or alkoxyalkyl)triphenylenes, 2,3,3a,3b,4,5,6,7,7a,11b-decahydro-6-(oxo, hydroxy or amino)-8-hydroxy-10-(alkyl, alkoxy or alkoxyalkyl)-1H-cyclopenta[1]phenanthrenes, 2,3,4,4a,4b,5,6,7,8,8a-decahydro-7-(oxo, hydroxy or amino)-9-hydroxy-11-(alkyl, alkoxy, alkoxyalkyl, aralkyl, aralkoxy, aryloxyalkyl or aralkoxyalkyl)-1H-pyrido[1,2-f]phenanthridines, and 1,2,3,3a,3b,4,5,6,7,7a-decahydro-6-(oxo, hydroxy or amino)-8-hydroxy-10-(alkyl, alkoxy or alkoxyalkyl)pyrrolo[1,2-f]phenanthridines and derivatives are valuable as central nervous system active agents or as intermediates to compounds having such activity.
    Type: Grant
    Filed: March 16, 1982
    Date of Patent: September 25, 1984
    Assignee: Pfizer Inc.
    Inventors: James F. Eggler, Michael R. Johnson, Lawrence S. Melvin, Jr.
  • Patent number: 4334106
    Abstract: An improved process is provided for the preparation of a certain class of hydroxyphenyl-indanol compounds by the cyclization of a phenol selected from the group consisting of an isopropenylphenol, oligomers thereof, and mixtures of any of said group in any combination and proportion, by dissolving said phenol in a stoichiometric excess of an organic acid selected from the group consisting of trifluoroacetic acid, trichloroacetic acid, difluoroacetic acid, dichloroacetic acid, fluoroacetic acid, chloroacetic acid, formic acid, and mixtures thereof at a temperature falling within a range of from about 0.degree. C. to about 90.degree. C. to form a solution; and maintaining said solution at a temperature falling within the above said range until the formation of said indanol is substantially complete.The dihydroxy compounds produced by the present method are useful in the preparation of epoxy, alkyd, and urethane resins in particular.
    Type: Grant
    Filed: February 5, 1981
    Date of Patent: June 8, 1982
    Assignee: The Upjohn Company
    Inventor: Shenghong A. Dai
  • Patent number: 4301306
    Abstract: Novel norbornenyl phenolics useful as antioxidants are defined by the following structural formula: ##STR1## where R.sup.1, R.sup.2, and R.sup.3 are individually selected from hydrogen and alkyl groups of 1 to 3 carbon atoms; R.sup.4 is selected from hydrogen, alkyl groups containing 1 to 12 carbon atoms, and substituted and unsubstituted alicyclic groups of 4 to 8 carbon atoms; R.sup.5 is selected from alkyl groups containing 1 to 6 carbon atoms, and substituted and unsubstituted alicyclic groups of 4 to 8 carbon atoms; R.sup.7 is selected from alkylene and alkenylene groups containing 1 to 8 carbon atoms; and R.sup.8 is selected from hydrogen, alkyl and alkenyl groups containing 1 to 8 carbon atoms.
    Type: Grant
    Filed: March 27, 1980
    Date of Patent: November 17, 1981
    Assignee: The B. F. Goodrich Company
    Inventor: Robert W. Layer
  • Patent number: 4219489
    Abstract: Method and compounds are provided for use in the synthesis of steroids wherein a polyolefin is provided having an initiating group having a chalcogen atom in juxtaposition to a double bond, so as to be capable of bond formation to close to form a ring and having a terminating group involving pi unsaturation (a double or triple bond) conjugated to an aromatic ring. Upon acid catalysis, sigma bonds are formed through the interaction of a carbocation formed at the carbon atom bonded to the chalcogen atom and the double bond intermediate the initiating group and the terminating group, which close to form rings of a steroid nucleus, the carbocation interacting with the pi unsaturation conjugated with the aromatic group and being captured by a nucleophile present in the acidic reaction medium. The resulting steroid product may then be modified in known ways to produce known steroids.
    Type: Grant
    Filed: September 5, 1978
    Date of Patent: August 26, 1980
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: William S. Johnson, Leonard A. Bunes
  • Patent number: 4182915
    Abstract: Process for the preparation of nucleophilically ring-substituted aromatic compounds from an aromatic-thallium (III) metallate is provided in which the aromatic-thallium (III) metallate is contacted with a source of the nucleophile to form the desired substituted aromatic compound, which may be recovered from the reaction mixture as by distillation. Exemplary processes include the preparation of aniline and phenol from benzene.
    Type: Grant
    Filed: January 24, 1977
    Date of Patent: January 8, 1980
    Assignee: Halcon International, Inc.
    Inventor: Robert J. Harvey
  • Patent number: 4178381
    Abstract: C-homoestratrienes of the formula ##STR1## wherein ##STR2## R.sub.1 and R.sub.2 are the same or different, and each is hydrogen, acyl, alkyl, cycloalkyl or tetrahydropyranyl; andR.sub.3 is hydrogen, ethynyl or chloroethynyl; possess very good estrogenic properties.
    Type: Grant
    Filed: December 4, 1978
    Date of Patent: December 11, 1979
    Assignee: Schering, Aktiengesellschaft
    Inventors: Gregor Haffer, Ulrich Eder, Gerhard Sauer, Rudolf Wiechert, Yukishige Nishino, Gunter Neef
  • Patent number: 4107206
    Abstract: The present invention relates to novel biologically active tricyclic compounds of the general formula: ##STR1## and salts thereof, IN WHICHR.sub.1 and R.sub.2 stand for hydroge, alkyl or alkenyl, an optionally substituted aralkyl group or an acyl group orR.sub.1 + r.sub.2 together with the nitrogen atom represent a heterocyclic 5- or 6-membered ring, andX and Y stand for hydrogen, hydroxy, halogen, alkyl or alkoxy of 1-6 carbon atoms, nitro, trifluoromethyl or an acyloxy group,Which compounds have valuable biological activities, particularly anorectic activity.
    Type: Grant
    Filed: October 26, 1976
    Date of Patent: August 15, 1978
    Assignee: Akzona Incorporated
    Inventors: Colin Leslie Hewett, David Samuel Savage